Salarius Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 192.7%.

Top 20 shareholders own 3.22% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
1.77%	Elvin Lee	25,534	US$38.8k	0%	no data
0.43%	David Arthur	6,142	US$9.3k	0%	no data
0.22%	Tower Research Capital Europe Limited	3,189	US$4.8k	0.35%	no data
0.21%	Geode Capital Management, LLC	3,096	US$4.7k	0%	no data
0.19%	Mark Rosenblum	2,731	US$4.2k	0%	no data
0.13%	The Vanguard Group, Inc.	1,820	US$2.8k	0%	no data
0.11%	Citigroup Inc.,Banking and Securities Investments	1,610	US$2.4k	0%	no data
0.029%	Arnold Hanish	412	US$626.3	0%	no data
0.026%	Jonathan Lieber	368	US$559.5	0%	no data
0.025%	William McVicar	357	US$542.6	0.28%	no data
0.024%	Tess Burleson	340	US$516.8	0%	no data
0.018%	UBS Asset Management AG	260	US$395.2	130%	no data
0.015%	Paul Lammers	215	US$326.8	0%	no data
0.012%	Bruce McCreedy	180	US$273.6	0%	no data
0.011%	Osaic Wealth, Inc. , Asset Management Arm	162	US$246.2	0%	no data
0.0011%	Bank of America Corporation, Asset Management Arm	16	US$24.3	300%	no data
0.00069%	Securities America Advisors, Inc.	10	US$15.1	0%	no data
0.00049%	Morgan Stanley, Investment Banking and Brokerage Investments	7	US$10.7	0%	no data
0.00014%	Merrill Lynch & Co. Inc., Banking Investments	2	US$3.1	0%	no data
0.00007%	BlackRock, Inc.	1	US$1.5	0%	no data